{"title":"急性st段抬高型心肌梗死的应激性高血糖是左室重构的标志。","authors":"Danijela Djordjevic-Radojkovic, Goran Koracevic, Dragana Stanojevic, Miodrag Damjanovic, Svetlana Apostolovic, Milan Pavlovic","doi":"10.3109/17482941.2013.781190","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Stress hyperglycemia (SH) in STEMI is associated with high risk of in-hospital mortality. It is still controversial if SH is marker of high post-hospital risk.</p><p><strong>Objectives: </strong>The aim was to analyze in-hospital and one-year risk associated with SH in STEMI and to study if SH is marker of LV remodeling.</p><p><strong>Methods: </strong>We enrolled 275 patients who were admitted with first STEMI and reperfused. Patients were divided according to admission glycemia in three groups: (1) with diabetes mellitus (DM); (2) with SH, without DM and; (3) without both DM and SH. SH was defined as admission blood glucose level ≥ 8 mmol/l.</p><p><strong>Results: </strong>In-hospital mortality was higher in patients with known DM (5%) and highest in patients with SH without previous DM (9.3%), and only 1.6% in the third group, P < 0.05. In patients without known DM, SH was associated with 6.378-fold higher in-hospital mortality. Total mortality was double in group with SH without DM compared to the third group (13.9% versus 6.3%). EDV changed in patients with SH without DM from 126 ± 37 to 145 ± 30 ml after one year, P < 0.05.</p><p><strong>Conclusion: </strong>SH is associated with high in-hospital mortality risk and it could be marker of LV remodeling (significant increase of EDV during one year).</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"15 2","pages":"38-43"},"PeriodicalIF":0.0000,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.781190","citationCount":"12","resultStr":"{\"title\":\"Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling.\",\"authors\":\"Danijela Djordjevic-Radojkovic, Goran Koracevic, Dragana Stanojevic, Miodrag Damjanovic, Svetlana Apostolovic, Milan Pavlovic\",\"doi\":\"10.3109/17482941.2013.781190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Stress hyperglycemia (SH) in STEMI is associated with high risk of in-hospital mortality. It is still controversial if SH is marker of high post-hospital risk.</p><p><strong>Objectives: </strong>The aim was to analyze in-hospital and one-year risk associated with SH in STEMI and to study if SH is marker of LV remodeling.</p><p><strong>Methods: </strong>We enrolled 275 patients who were admitted with first STEMI and reperfused. Patients were divided according to admission glycemia in three groups: (1) with diabetes mellitus (DM); (2) with SH, without DM and; (3) without both DM and SH. SH was defined as admission blood glucose level ≥ 8 mmol/l.</p><p><strong>Results: </strong>In-hospital mortality was higher in patients with known DM (5%) and highest in patients with SH without previous DM (9.3%), and only 1.6% in the third group, P < 0.05. In patients without known DM, SH was associated with 6.378-fold higher in-hospital mortality. Total mortality was double in group with SH without DM compared to the third group (13.9% versus 6.3%). EDV changed in patients with SH without DM from 126 ± 37 to 145 ± 30 ml after one year, P < 0.05.</p><p><strong>Conclusion: </strong>SH is associated with high in-hospital mortality risk and it could be marker of LV remodeling (significant increase of EDV during one year).</p>\",\"PeriodicalId\":87385,\"journal\":{\"name\":\"Acute cardiac care\",\"volume\":\"15 2\",\"pages\":\"38-43\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3109/17482941.2013.781190\",\"citationCount\":\"12\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acute cardiac care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/17482941.2013.781190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acute cardiac care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/17482941.2013.781190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
摘要
STEMI患者的应激性高血糖(SH)与院内死亡的高风险相关。SH是否是高出院后风险的标志仍然存在争议。目的:分析STEMI患者与SH相关的住院和1年风险,并研究SH是否为左室重构的标志。方法:我们招募了275例首次STEMI并再灌注的患者。根据入院血糖将患者分为三组:(1)合并糖尿病(DM);(2)含SH,不含DM;(3)无糖尿病和SH, SH定义为入院血糖≥8 mmol/l。结果:已知糖尿病患者住院死亡率最高(5%),无糖尿病的SH患者住院死亡率最高(9.3%),第三组仅为1.6%,P < 0.05。在没有已知糖尿病的患者中,SH与住院死亡率高6.378倍相关。SH无DM组的总死亡率是第三组的两倍(13.9%对6.3%)。SH无DM患者1年后EDV由126±37 ml降至145±30 ml, P < 0.05。结论:SH与院内死亡风险高相关,可能是左室重构的标志(一年内EDV显著增加)。
Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling.
Introduction: Stress hyperglycemia (SH) in STEMI is associated with high risk of in-hospital mortality. It is still controversial if SH is marker of high post-hospital risk.
Objectives: The aim was to analyze in-hospital and one-year risk associated with SH in STEMI and to study if SH is marker of LV remodeling.
Methods: We enrolled 275 patients who were admitted with first STEMI and reperfused. Patients were divided according to admission glycemia in three groups: (1) with diabetes mellitus (DM); (2) with SH, without DM and; (3) without both DM and SH. SH was defined as admission blood glucose level ≥ 8 mmol/l.
Results: In-hospital mortality was higher in patients with known DM (5%) and highest in patients with SH without previous DM (9.3%), and only 1.6% in the third group, P < 0.05. In patients without known DM, SH was associated with 6.378-fold higher in-hospital mortality. Total mortality was double in group with SH without DM compared to the third group (13.9% versus 6.3%). EDV changed in patients with SH without DM from 126 ± 37 to 145 ± 30 ml after one year, P < 0.05.
Conclusion: SH is associated with high in-hospital mortality risk and it could be marker of LV remodeling (significant increase of EDV during one year).